欧洲各地新冠疫苗接种犹豫:面向未来的教训
研究基于Flash Eurobarometer 505覆盖全部27个欧盟成员国的N=26,641数据,采用模糊聚类与grade of membership模型构建对新冠疫苗接种态度的类型学,并建立0-1分的态度指数(IA)。结果显示欧盟27国公民总体不反对新冠疫苗接种(指数均值=0.44),但部分国家主要是东欧国家偏离这一主流趋势;对各类疫苗安全性和有效性的不信任以及对欧洲和国家机构的不信任与接种犹豫相关。
要点
- 欧盟27国公民总体不反对新冠疫苗接种,态度指数均值为0.44(0-1分)。
- 对各类疫苗安全性和有效性的不信任及对欧洲和国家机构的不信任与新冠疫苗接种犹豫相关。
- 接种犹豫程度因国家而异,部分东欧国家偏离欧盟整体趋势。
核心结论
- 对各类疫苗安全性和有效性的不信任以及对欧洲和国家机构的不信任与新冠疫苗接种犹豫相关,且这种犹豫因国家而异。
- 研究结果可为国家和卫生机构提供信息,并有助于制定沟通策略以触达最犹豫的公民。
- 所提供的分类使定制宣传活动更为容易,以提高对不接种疫苗后果的认识,尤其是在新SARS-CoV-2变异株出现时。
研究设计与样本
- 研究基于Flash Eurobarometer 505数据,覆盖全部27个欧盟成员国,样本量N=26,641。
- 采用模糊聚类方法构建对新冠疫苗接种态度的类型学,并建立态度指数(IA)以反映欧盟公民的个体定位。
- 数据分析基于grade of membership(GoM)模型,该模型是处理异质性人群的可靠统计工具。
主要发现
- GoM模型输出揭示了层级模糊三分类,对应三种明确识别的新冠疫苗接种感受类型:类型1为有利感受,类型2为中等有利感受,类型3为对新冠疫苗的怀疑。
- 态度指数(IA)以0-1分量化了欧洲公民对新冠疫苗接种的情绪,显示欧盟27国公民总体不反对新冠疫苗接种(指数均值=0.44)。
- 部分公民主要在东欧国家偏离这一主流趋势。
关键数值与推荐
- 态度指数(IA)采用0-1分制,欧盟27国公民的指数均值=0.44。
- GoM模型识别出三种类型:类型1(有利感受)、类型2(中等有利感受)、类型3(对新冠疫苗的怀疑)。
临床怎么用
- 研究结果可为国家和卫生机构提供信息,并有助于制定沟通策略以触达最犹豫的公民。
- 研究提供的分类使定制宣传活动更为容易,以提高对不接种疫苗后果的认识,尤其是在新SARS-CoV-2变异株出现时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccine reluctance is both a complex and context-specific issue and is the result of many complicating factors that need to be addressed more systematically. In Europe, several country-based ad-hoc studies have been carried out on COVID-19 vaccines/vaccination and vaccine reluctance but a comprehensive overview covering all 27 European Union (EU27) countries is lacking. Such study can help understand vaccine reluctance in the overall EU as well as examine differences between individual countries. METHODS: This study relies on data from Flash Eurobarometer 505, covering all 27 European Union member states; the sample size is N=26,641. It takes a fuzzy clustering approach to construct typologies of attitudes towards COVID-19 vaccination, and subsequently develops an "Index of Attitudes" (IA) which accounts for individual positioning of EU citizens. The data analysis is based on grade of membership (GoM) model which is a reliable statistical tool to tackle heterogeneous populations. RESULTS: The output of GoM model unveiled a hierarchical fuzzy 3-partition corresponding to three clearly identified typologies of feelings towards COVID-19 vaccination: Typology 1 entails favourable feelings while moderate-favourable feelings describe the Typology 2. Finally, Tipology 3 encompasses the scepticism towards COVID-19 vaccines. The IA, which quantifies the sentiment of European citizens towards COVID-19 vaccination in a 0-1 scale, reveals that although EU27 citizens overall are not against COVID-19 vaccination (index mean =0.44) some, mostly in eastern countries, deviate from this prevailing trend. CONCLUSION: Distrust in the safety and efficacy of all kinds of vaccines, as well as a generalised distrust in European and national institutions, are associated with the reluctance in relation towards COVID-19 vaccination. However, this reluctance varies across countries. The outcomes of our study not only inform national government and health care agents but also help define communication strategies to reach the most reluctant citizens. The segmentation it provides makes it easier to customise campaigns that raise awareness of the consequences of not being vaccinated, particularly as new SARS-CoV-2 variants emerge.
引用
- Suleman A, Vicente P. COVID-19 vaccination reluctance across Europe: Lessons for the future. Vaccine. 2024. PMID: 39069463. doi:10.1016/j.vaccine.2024.126168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。